Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference20 articles.
1. Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, et al. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 2020;369:m1590. https://doi.org/10.1136/bmj.m1590.
2. European Medicines Agency. Stelara: Summary of product characteristics. 2022. https://www.ema.europa.eu/en/documents/product-information/stelara-epar-product-information_en.pdf. Accessed 30 May 2023.
3. US Food & Drug Administration. Stelara: prescribing information. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761044s010lbl.pdf. Accessed 30 May 2023.
4. Benson JM, Peritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. MAbs. 2011;3(6):535–45. https://doi.org/10.4161/mabs.3.6.17815.
5. Brodmerkel C, Li K, Garcet S, Hayden K, Chiricozzi A, Novitskaya I, et al. Modulation of inflammatory gene transcripts in psoriasis vulgaris: differences between ustekinumab and etanercept. J Allergy Clin Immunol. 2019;143(5):1965–9. https://doi.org/10.1016/j.jaci.2019.01.017.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献